Concepedia

Xue’er Wang

XW

Statistics

Publications

1

Citations

19

H-Index

1

Active since

2023

Affiliations

Simcere Pharmaceutical (China)(Current)

Xue’er Wang is an author at Simcere Pharmaceutical (China) specializing in triple-negative breast cancer therapy, immunotherapy, and neoadjuvant therapy trials.

Publications per year

2023–2023

1

Publications

1

Clinical efficacy and biomarker analysis of neoadjuvant camrelizumab plus chemotherapy for early-stage triple-negative breast cancer: a experimental single-arm phase II clinical trial pilot study

Chunhui Zheng, Yanbing Liu, Xue’er Wang et al. · International Journal of Surgery · 2023 · 19 citations · Full text

Medicine, Oncology, Pharmacology +17

1–1 of 1